Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Regulation topic
No spam. Unsubscribe anytime.
OPOR director briefs board on DEA mail‑order attestation and upcoming rulemaking
Summary
OPOR Director Penny Vaillancourt told the board about a DEA mail‑order pharmacy rule and an attestation form for companies without a DEA number; she also noted upcoming joint rulemaking with the Board of Complementary Medicine and a volunteer pharmacist for a formulary subcommittee.
OPOR Director Penny Vaillancourt briefed the Board of Pharmacy on a DEA rule requirement affecting mail‑order pharmacies and provided the board with a DEA attestation form intended for companies that do not have a DEA number. "OPOR Director Penny Vaillancourt discussed with board the DEA rule requirement for mail order pharmacies, and a DEA attestation form created for companies without a DEA number, a copy was provided to the board for review," the minutes state.
Vaillancourt also alerted members to upcoming joint rulemaking with the Board of Complementary Medicine; Board member Nicholas Haar volunteered to serve as the pharmacist on a subcommittee working on the formulary list. The minutes record no objection to Haar serving on the subcommittee; OPOR staff will carry forward rulemaking logistics.
